comprehensive -WSS

comprehensive

author：focus 2025-09-28 01:34:54 - browse：29786

U.S. President Joe Biden stands with his fingers locked next to an US flag — politics coverage from STAT — President Biden's White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs.

WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort to draw attention to the program in an election year.

The news is not controversial: The pharmaceutical companies that make the first ten drugs up for negotiation all submitted counteroffers. It’s an incremental step in the new program, which was created in 2022.

Earlier this year, Medicare sent its initial price offers to the companies. Neither the Biden administration nor the drug manufacturers have volunteered any information about the White House’s initial price offers or the counteroffers. The process is scheduled to end by Aug. 1.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Sanofi CEO defends move to abandon profit guidance, boost research

leisure time

WSS

Why hospitals are withdrawing from US News rankings

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

FDA approves potent Eli Lilly obesity drug, Zepbound

In early work, researchers turn to CRISPR to treat Alzheimer's

In early work, researchers turn to CRISPR to treat Alzheimer's

Ambulance rides for just $100? Advisers want major billing fixes

focus

comprehensive

hotspot

Heart attack and stroke risk calculators need revising

Abortion clinic in Cancun will cater to Americans

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Google and Epic fight stronger regulation of AI in health care

Virginia high school admissions case could be legal follow

In early work, researchers turn to CRISPR to treat Alzheimer's

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Abortion clinic in Cancun will cater to Americans

Continuity nursing helped my family in our darkest PICU moments

At Orexo, a ‘turning point’ for everything but digital health

entertainment

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Startup Neumora takes a novel depression drug to Phase 3

HPV cancer vaccine study demonstrates efficacy

Google and Epic fight stronger regulation of AI in health care

Sanofi CEO defends move to abandon profit guidance, boost research

entertainment

leisure time

hotspot

Wikipedia